Approval · Notice of Compliance 11512 · 2010
OLUX-E: Notice of Compliance 11512
Issued June 16, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11512
- Date
- June 16, 2010
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical corticosteroid therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OLUX-E | 02344408 | Cancelled Post Market |
Medicinal ingredients
- CLOBETASOL PROPIONATE 0.05 PER